Cancer Australia

A range of evidence-based clinical practice guidelines, guides and recommendations have been developed to assist decision making and guide best practice in the management of breast and ovarian cancer, and other cancers where relevant.

Early breast cancer

Recommendations for
Follow-up of women with
early breast cancer

Recommendations for
Aromatase inhibitors as
adjuvant endocrine therapy
for post-menopausal women with hormone receptor-positive early breast cancer

Recommendations for use of
Sentinel node biopsy
in early (operable) breast cancer

Recommendations for use of
Taxane-containing
chemotherapy regimens for the treatment of early (operable) breast cancer

Recommendations for
staging and managing the axilla
in early (operable) breast cancer

Recommendations for use of
hypofractionated radiotherapy
in early (operable) breast cancer

Recommendations for use of
bisphosphonates
in early breast cancer

Advanced breast cancer

Recommendations for use of
Trastuzumab (Herceptin®)
for the treatment of HER2-positive breast cancer

Recommendations for use of
Endocrine therapy
for the treatment of hormone receptor-positive advanced breast cancer

Recommendations for use of
chemotherapy
for the treatment of advanced breast cancer

Recommendations for use of
bisphosphonates
for advanced breast cancer

Ovarian cancer

Recommendations for the management
of women at high risk
of ovarian cancer